Eli Lilly

In This Story LLY NVO HIMS The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug...

Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signalin...

Hims & Hers Health Inc HIMS shares are trading lower Thursday in possible sympathy with Eli Lilly And Co’s LLY, after the U.S. Food and Drug Administration remo...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about R...

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. View comments...

Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and Drug Administration (FDA) said on Wedn...

Pharmaceutical company Eli Lilly (LLY) says it will spend $4.5 billion to create a new research and manufacturing center for the development of future medicatio...

Eli Lilly and Co LLY is making a major move with a $4.5 billion investment to create the Lilly Medicine Foundry, a new research and manufacturing facility. The...

Eli Lilly (NYSE:LLY) has been a standout name over the past couple of years, with its strong position in the booming trend of weight-loss drugs contributing to...

Eli Lilly (LLY) is considering testing its blockbuster weight-loss drugs in individuals who are not yet overweight but are at risk of weight gain, according to...